![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel | Konferenzbeitrag
Anzahl der Publikationen: 11
Zeitschriftenartikel
Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Kaiser, L.; Brendel, M.; Vettermann, F. J.; Holzgreve, A. und Bartenstein, P.
(2020):
In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein.
In: European journal of nuclear medicine and molecular imaging, Bd. 47, Nr. 10: S. 2237-2241
[PDF, 975kB]
ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Kaiser, L.; Brendel, M.; Vettermann, F. J.; Holzgreve, A. und Bartenstein, P.
(2020):
In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein.
In: European journal of nuclear medicine and molecular imaging, Bd. 47, Nr. 10: S. 2237-2241
[PDF, 975kB]
Unterrainer, M.; Fleischmann, D. F.; Vettermann, F.; Ruf, V.; Kaiser, L.; Nelwan, D.; Lindner, S.; Brendel, M.; Wenter, V.; Stoecklein, S.; Herms, J.; Milenkovic, V. M.; Rupprecht, R.; Tonn, J. C.; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825; Bartenstein, Peter; Niyazi, Maximilian und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2020):
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-18-GE-180 PET study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 6: S. 1368-1380
ORCID: https://orcid.org/0000-0002-1287-7825; Bartenstein, Peter; Niyazi, Maximilian und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2020):
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-18-GE-180 PET study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 6: S. 1368-1380
Ilhan, Harun; Lindner, S.; Todica, A.; Cyran, C. C.; Tiling, R.; Auernhammer, C. J.; Spitzweg, C.; Boeck, S.; Unterrainer, M.; Gildehaus, F. J.; Böning, G.; Jurkschat, K.; Wängler, C.; Wängler, B.; Schirrmacher, R. und Bartenstein, P.
(2020):
Biodistribution and first clinical results of F-18-SiFAlin-TATE PET: a novel F-18-labeled somatostatin analog for imaging of neuroendocrine tumors.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 4: S. 870-880
Unterrainer, M.; Eze, C.; Ilhan, H.; Marschner, S.; Roengvoraphoj, O.; Schmidt-Hegemann, N. S.; Walter, F.; Kunz, W. G.; Munck af Rosenschold, P.; Jeraj, R.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
A look ahead: future directions of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
A look ahead: future directions of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362
Rudisile, S.; Gosewisch, A.; Wenter, V; Unterrainer, M.; Boening, G.; Gildehaus, F. J.; Fendler, W. P.; Auernhammer, C. J.; Spitzweg, C.; Bartenstein, P.; Todica, A. und Ilhan, H.
(2019):
Salvage PRRT with Lu-177-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival.
In: BMC Cancer, Bd. 19, Nr. 1, 788
Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Current status of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Current status of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180
Unterrainer, M.; Winkelmann, I.; Suchorska, B.; Giese, A.; Wenter, V.; Kreth, F. W.; Herms, J.; Bartenstein, P.; Tonn, J. C. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Biological tumour volumes of gliomas in early and standard 20-40 min F-18-FET PET images differ according to IDH mutation status.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 7: S. 1242-1249
ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Biological tumour volumes of gliomas in early and standard 20-40 min F-18-FET PET images differ according to IDH mutation status.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 7: S. 1242-1249
Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Fleischmann, D. F.; Lindner, S.; Vettermann, F.; Brunegraf, A.; Vomacka, L.; Brendel, M.; Wenter, V.; Wetzel, C.; Rupprecht, R.; Tonn, J.-C.; Belka, C.; Bartenstein, P. und Niyazi, M.
(2017):
TSPO PET for glioma imaging using the novel ligand F-18-GE-180: first results in patients with glioblastoma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 13: S. 2230-2238
ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Fleischmann, D. F.; Lindner, S.; Vettermann, F.; Brunegraf, A.; Vomacka, L.; Brendel, M.; Wenter, V.; Wetzel, C.; Rupprecht, R.; Tonn, J.-C.; Belka, C.; Bartenstein, P. und Niyazi, M.
(2017):
TSPO PET for glioma imaging using the novel ligand F-18-GE-180: first results in patients with glioblastoma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 13: S. 2230-2238
Vomacka, L.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Mille, E.; Suchorska, B.; Unterrainer, M.; Gosewisch, A.; Bartenstein, P. und Boening, G.
(2016):
3D analysis of glioma heterogeneity with pseudo-kinetic and pharmacokinetic model parameters in dynamic 18F-FET PET.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S194-S194
ORCID: https://orcid.org/0000-0003-0953-7624; Mille, E.; Suchorska, B.; Unterrainer, M.; Gosewisch, A.; Bartenstein, P. und Boening, G.
(2016):
3D analysis of glioma heterogeneity with pseudo-kinetic and pharmacokinetic model parameters in dynamic 18F-FET PET.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S194-S194
Konferenzbeitrag
Mahler, C.; Unterrainer, M.; Vomacka, L.; Lindner, S.; Brendel, M.; Brunegraf, A.; Kümpfel, T.; Rupprecht, R.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624 und Kerschensteiner, M.
(2017):
[18F]GE-180, a novel TSPO-PET tracer for visualization of inflammatory CNS-activity in MS.
MSParis2017, Paris, France, 25-28 October 2017.
Multiple Sclerosis Journal.
Bd. 23, Nr. S3
Sage Publications. S. 81
ORCID: https://orcid.org/0000-0003-0953-7624 und Kerschensteiner, M.
(2017):
[18F]GE-180, a novel TSPO-PET tracer for visualization of inflammatory CNS-activity in MS.
MSParis2017, Paris, France, 25-28 October 2017.
Multiple Sclerosis Journal.
Bd. 23, Nr. S3
Sage Publications. S. 81